HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Clear lens phacoemulsification with continuous curvilinear capsulorhexis and foldable intraocular lens implantation for the treatment of a patient with bilateral anterior lenticonus due to Alport syndrome.

Abstract
The case of a 29-year-old man is reported who presented with a gradually progressive, painless decrease in vision over 10 years. Anterior segment examination with a slit lamp revealed anterior lenticonus in both eyes. The patient had previously been diagnosed with bilateral sensorineural deafness, however investigations revealed microscopic haematuria and renal insufficiency that subsequently led to a diagnosis of classical Alport syndrome. Since the patient's quality of vision was severely affected by the bulging anterior lens capsule, surgical treatment was required. Clear lens phacoemulsification with continuous curvilinear capsulorhexis and foldable intraocular lens implantation were performed in each eye 2 days apart. One week after surgery, visual acuity was excellent in both eyes. Clear lens phacoemulsification with continuous curvilinear capsulorhexis and foldable intraocular lens implantation was a safe and effective therapeutic choice in this patient for the management of anterior lenticonus due to Alport syndrome.
AuthorsY B Liu, S J Tan, Z Y Sun, X Li, B Y Huang, Q M Hu
JournalThe Journal of international medical research (J Int Med Res) 2008 Nov-Dec Vol. 36 Issue 6 Pg. 1440-4 ISSN: 0300-0605 [Print] England
PMID19094456 (Publication Type: Case Reports, Journal Article)
Topics
  • Adult
  • Anterior Eye Segment (pathology)
  • Capsulorhexis (methods)
  • Humans
  • Lens Diseases (complications, pathology, surgery)
  • Lens Implantation, Intraocular
  • Male
  • Nephritis, Hereditary (complications, pathology)
  • Phacoemulsification (methods)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: